Alloantiserum recognizing a DQw2 split which is associated with DR3

Area of Science:

• Immunogenetics
• Human Leukocyte Antigen (HLA) complex

Background:

• The Human Leukocyte Antigen (HLA) complex plays a crucial role in immune response.
• Specific HLA alleles, such as DR3 and DQw2, are associated with various autoimmune diseases.
• Accurate typing of HLA antigens is essential for transplantation and disease association studies.

Purpose of the Study:

• To characterize a newly identified typing serum, MUE 38539 II.
• To determine the specificity of MUE 38539 II within the HLA system, particularly concerning DR3 and DQw2.
• To investigate the potential of MUE 38539 II as a tool for identifying specific HLA antigen associations.

Main Methods:

• Cytotoxicity testing using MUE 38539 II on B lymphocytes and monocytes from DR3-positive donors.
• Lymphocytotoxicity tests with MUE 38539 II on DR7- and DQw2-positive cells.
• Testing reactivity against a DQw4- and DR3-positive lymphoblastoid cell line (RSH).
• Analysis of HLA antigen linkage in a family with unusual DR3 and DQw2 associations.

Main Results:

• Serum MUE 38539 II demonstrated specific reactivity with B lymphocytes, but not monocytes, of DR3-positive individuals.
• The serum showed negative results with DR7- and DQw2-positive cells.
• MUE 38539 II did not react with the RSH cell line, supporting its specificity for a DQw2 split, not DR3.
• Exclusively cytotoxic reactions were observed with DQw2-positive cells, irrespective of DR3 presence, in family studies.

Conclusions:

• Serum MUE 38539 II recognizes a specific subtype of DQw2 antigen, which is associated with DR3.
• This serum's specificity differs from other DR3 typing reagents.
• MUE 38539 II provides a valuable tool for dissecting complex HLA associations, particularly involving DQw2 and DR3.